Professionals in Morocco's dietary supplement industry are protesting an amendment to the country's drug law, which they argue would grant a monopoly to a single operator. The Coalition of Companies in the Dietary Supplement Sector, representing businesses across the value chain, has launched a petition against the measure.
The amendment, introduced during parliamentary debate on the draft drug law, would restrict the import and distribution of dietary supplements to a single entity. Critics say this would stifle competition, raise prices, and threaten thousands of jobs in a sector that has grown significantly in recent years.
According to the coalition, the current market includes dozens of small and medium-sized enterprises that comply with national regulations. They warn that the amendment contradicts the government's stated goals of supporting entrepreneurship and free trade. The petition has gathered signatures from industry stakeholders and calls on lawmakers to reject the change.
As of June 2026, the draft law is still under review in the Moroccan parliament. No official statement from the Ministry of Health has been issued regarding the amendment. The coalition plans to continue lobbying against the provision.
